Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
BioHarvest Sciences Inc. Common Stock · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $172.43M | $164.28M - $180.64M | -$115.56M | $1.50 | 1 |
| Dec 2029 | $129.45M | $123.33M - $135.61M | -$86.75M | $0.83 | 2 |
| Dec 2028 | $96.15M | $91.61M - $100.73M | -$64.44M | $0.405 | 1 |
| Dec 2027 | $58.96M | $57.45M - $60.46M | -$39.51M | -$0.163 | 3 |
| Dec 2026 | $42.89M | $41.93M - $43.85M | -$28.74M | -$0.395 | 3 |
| Dec 2025 | $34.68M | $34.54M - $34.82M | -$23.24M | -$0.618 | 3 |
| Dec 2024 | $25.15M | $25.07M - $25.22M | -$16.85M | -$0.78 | 2 |